Curvularin

Curvularin

SCHEMBL29928932

C[C@H]1CCCCCC(=O)c2c(O)cc(O)cc2CC(=O)O1

nearest known ligand 0.65

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPT P10636 2/20 0.64
GEMIN4 P57678 1/20 0.64
HSF1 Q00613 1/20 0.64
NPC1 O15118 1/20 0.64
MITF O75030 1/20 0.64
RAB9A P51151 1/20 0.64
ATM Q13315 1/20 0.64
NPSR1 Q6W5P4 1/20 0.64
LMNA P02545 5/20 0.59
SMN1; SMN2 Q16637 5/20 0.59
ESR2 Q92731 4/20 0.59
ALDH1A1 P00352 4/20 0.59
HSP90AA1 P07900 3/20 0.59
HSP90AB1 P08238 3/20 0.59
CYP3A4 P08684 3/20 0.59
NR1I2 O75469 2/20 0.59
TP53 P04637 1/20 0.59
POLB P06746 1/20 0.59
F13A1 P00488 1/20 0.52
TGM2 P21980 1/20 0.52

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Curvularin SCHEMBL15256930 1.00 MAPT (0.64) MAPTGEMIN4HSF1NPC1MITF
Curvularin SCHEMBL2140562 1.00 MAPT (0.64) MAPTGEMIN4HSF1NPC1MITF
Curvularin SCHEMBL30556710 1.00 MAPT (0.64) MAPTGEMIN4HSF1NPC1MITF
Xestodecalactone A SCHEMBL2874661 0.95 MAPT (0.67) MAPTGEMIN4HSF1NPC1MITF
SCHEMBL18543028 0.83 MAPT (0.61) MAPTGEMIN4HSF1NPC1MITF
SCHEMBL15258429 0.80 LMNA (0.80) MAPTGEMIN4HSF1NPC1MITF
SCHEMBL869065 0.79 LMNA (0.88) MAPTLMNASMN1; SMN2ESR2ALDH1A1
SCHEMBL29737259 0.79 LMNA (0.88) MAPTLMNASMN1; SMN2ESR2ALDH1A1
SCHEMBL31217635 0.79 LMNA (0.88) MAPTLMNASMN1; SMN2ESR2ALDH1A1
SCHEMBL30163150 0.79 LMNA (0.88) MAPTLMNASMN1; SMN2ESR2ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20240315965-A1 COMPOSITIONS AND METHODS RELATED TO PHARMACEUTICAL EXCIPIENTS Natural Extraction Systems, LLC (US) 2024-09-26 US claimed
WO-2022182527-A1 COMPOSITIONS AND METHODS RELATED TO PHARMACEUTICAL EXCIPIENTS Natural Extraction Systems, LLC (US) 2022-09-01 WO claimed